Axis Capital Holdings Ltd. (AXS) Financials Nov 18, 2014,
Axis Capital Holdings Ltd. (AXS) Financials Nov 18, 2014, 2:19 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Axis Capital Holdings Ltd.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 3.15B 3.57B 3.82B 3.95B 4.2B
Premiums Earned 2.79B 2.95B 3.31B 3.42B 3.71B
Total Investment Income 464.48M 406.89M 362.43M 380.96M 409.31M
Realized Gains (Losses) 25.85M 213.03M 137.3M 151.7M 77.2M
Other Operating Income (129.68M) 2.07M 2.4M 2.68M 4.42M
Losses, Claims & Reserves 1.42B 1.68B 2.68B 2.1B 2.13B
Losses, Benefits & Adjustments 1.42B 1.68B 2.68B 2.1B 2.13B
2009 2010 2011 2012 2013 5-year trend
Selling, General & Admin. Expenses & Other 790.65M 938.6M 1.05B 1.19B 1.23B
Selling, General & Admin. Expenses 790.65M 938.6M 1.03B 1.17B 1.22B
Other Selling, General & Admin. Expense 370.16M 449.89M 442.25M 547.16M 552.12M
Underwriting & Commissions 420.5M 488.71M 587.47M 627.65M 664.19M
Other Operating Expense 0 0 16.91M 13.82M 15.54M
Operating Income Before Interest Expense 937.89M 953.68M 95.42M 666.14M 831.95M
Interest Expense, Net of Interest Capitalized 32.03M 55.88M 62.6M 61.86M 61.98M
Interest Expense (excl. Interest Capitalized) 32.03M 55.88M 62.6M 61.86M 61.98M
Interest Capitalized 0 0 0 0 0
Operating Income After Interest Expense 905.86M 897.8M 32.82M 604.27M 769.97M
Non-Operating Income (Expense) (28.56M) 15.54M 44.58M (29.51M) (26.14M)
Miscellaneous Non Operating Expense (28.56M) 15.54M 44.58M (29.51M) (26.14M)
Equity in Affiliates (Pretax) 0 0 0 0 0
Unusual Expense 337.44M 17.93M 15.86M 24.23M 9.36M
Pretax Income 539.86M 895.4M 61.54M 550.53M 734.47M
Income Taxes 41.98M 38.68M 15.23M 3.29M 7M
Income Tax - Current - Domestic 32.59M 26.63M 5.06M 4.93M 12.47M
Income Tax - Current - Foreign 7.02M 12.29M 9.79M 8.39M 9.04M
Income Tax - Deferred - Domestic 2.25M 121,000 1.38M (10.75M) (13.98M)
Income Tax - Deferred - Foreign 113,000 (367,000) (996,000) 713,000 (527,000)
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - 0 (14.01M) (3.08M)
Consolidated Net Income 497.89M 856.72M 46.31M 533.23M 724.38M
Minority Interest Expense 0 0 0 0 -
Net Income 497.89M 856.72M 46.31M 533.23M 724.38M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 497.89M 856.72M 46.31M 533.23M 724.38M
Preferred Dividends 36.88M 36.88M 36.88M 38.23M 40.47M
Net Income Available to Common 461.01M 819.85M 9.43M 495M 683.91M
EPS (Basic) 3.36 6.74 0.08 4.05 6.02
Basic Shares Outstanding 137.28M 121.73M 122.5M 122.15M 113.64M
EPS (Diluted) 3.07 6.02 0.07 4.00 5.93
Diluted Shares Outstanding 150.37M 136.2M 128.12M 123.65M 115.33M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...
Continue Reading
Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....
Continue Reading
Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...
Continue Reading
Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...
Continue Reading
Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...
Continue Reading
Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...
Continue Reading
Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...
Continue Reading
Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...
Continue Reading
The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...
Continue Reading
Top 5 Most Recently Viewed Articles
Virbac's Impressive Growth in Early 2025 In an exciting development for Virbac, the company has announced a remarkable revenue growth of +5.6% for the first half of 2025, adjusted for constant exchange rates and considering its consolidation scope. This growth speaks volumes about the ability of Virbac to adapt and thrive in a competitive animal health market. Key...
Continue Reading
Amprius Technologies Ships Advanced EV Cells Amprius Technologies, Inc. (NYSE: AMPX), a pioneer in high-performance lithium-ion batteries, has made a significant advancement by delivering its SiMaxx™ A-Sample EV Cells to a prominent consortium that focuses on developing cutting-edge battery technologies. This collaboration aims to address crucial performance and cost...
Continue Reading
Jyske Bank A/S Completes Significant Bond Offering Jyske Bank A/S has successfully concluded a substantial bond offering, demonstrating confidence in its financial health and the stability of the market. This bond issuance, involving a total of 750 million euros, was categorized as a EUR 6.25NC5.25 Reg S Eurobond. Notably, it has been officially listed on the Dublin stock...
Continue Reading
Nitrado's Rise in Game Server Hosting Nitrado has gained significant recognition in recent times as a provider of game server hosting, particularly in its ability to cater to a variety of online multiplayer games. As renovations within the gaming industry continue, the need for dependable hosting solutions has escalated. Players want uninterrupted gameplay, enhanced...
Continue Reading
Windtree Therapeutics Inc. Celebrates Stockholder Approvals Windtree Therapeutics Inc. (NASDAQ: WINT), a notable biotechnology company focused on innovative biological solutions, is excited to share the successful outcomes from its Annual Meeting of Stockholders. This important meeting, which took place online, showcased the commitment and support of its dedicated...
Continue Reading